Company attributes
B2X
CEO
AngelList URL
Pitchbook URL
Legal Name
Syros Pharmaceuticals, Inc.0
Subsidiary
Legal classification
Date Incorporated
2011
Number of Employees (Ranges)
51 – 200
Email Address
info@syros.com0
medaffairs@syros.com0
Phone Number
+161774413400
Number of Employees
1240
Full Address
35 CambridgePark Drive 4th Floor Cambridge, MA 02140 United States0
CIK Number
Place of Incorporation
Investors
DUNS Number
0787372040
IRS Number
453,772,4600
Founded Date
2012
0Total Funding Amount (USD)
670,202,716
Latest Funding Round Date
September 21, 2022
Competitors
Stock Symbol
SYRS0
Exchange
Board of Directors
CFO
Latest Funding Type
NAICS Code
325,4120
CAGE Code
6W8S00
Patents Assigned (Count)
17
Wellfound ID
Country
Other attributes
Blog
Company Operating Status
Active
Contact Page URL
Latest Funding Round Amount (USD)
129,843,346
Previous Name
LS22, Inc.0
SIC Code
2,8340
Ticker Symbol
SYRS0
Syros Pharmaceuticals is a biopharmaceutical company that specializes in developing treatments for cancer and immune-mediated diseases, as well as building a pipeline of gene control medicines.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
